Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.3K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.3K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

218
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
218
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

868
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
868
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

170
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
170
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

254
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
254
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

254
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
254

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early-life stress and adolescent circadian dysrhythmia drives unique behavioral and microbial profiles in rats.

BMC microbiology·2026
Same author

Fascia's role in the mind-body continuum: a novel target for integrative treatments in psychiatry.

Frontiers in psychiatry·2026
Same author

Different screw configurations for treating Sanders type IIB intra-articular calcaneal fractures: a finite element analysis.

BMC musculoskeletal disorders·2026
Same author

Spectrophotometric evaluation of sun protection and antioxidant potential of Artemisia maritima L. and Sophora mollis Royle from Hunza, Gilgit-Baltistan.

Pakistan journal of pharmaceutical sciences·2026
Same author

Persistence of Proliferating Neural Progenitors in the Adult Human Hippocampus: New Evidence from snRNA-seq and Machine Learning Integration.

Neuroscience bulletin·2025
Same author

Niacin, an active form of vitamin B3, exerts antiviral function by recruiting β-arrestin through GPR109A to activate the phosphorylation of ERK and STAT1 axis.

Journal of virology·2025
Same journal

Epigenetic plasticity and chemoresistance in cancer: mechanisms, biomarkers, and translational opportunities for real-world evidence.

Frontiers in cell and developmental biology·2026
Same journal

Matched embryo-endometrium RNA-seq reveals coordinated but asymmetric transcriptomic reprogramming at the onset of early equine pregnancy.

Frontiers in cell and developmental biology·2026
Same journal

Myelin development in the peripheral nervous system of <i>Trachemys scripta</i>.

Frontiers in cell and developmental biology·2026
Same journal

A deep learning-based classification method for subclinical zonular laxity in AS-OCT images.

Frontiers in cell and developmental biology·2026
Same journal

Advancing fat graft survival: from adipose-derived stem cell mechanisms to next-generation regenerative strategies.

Frontiers in cell and developmental biology·2026
Same journal

CRISPR-based next-generation molecular diagnostics for bone infection.

Frontiers in cell and developmental biology·2026
See all related articles

Related Experiment Video

Updated: Nov 4, 2025

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
07:51

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

17.6K

GABAergic System Dysfunction and Challenges in Schizophrenia Research.

Muhammad Jahangir1, Jian-Song Zhou1, Bing Lang1,2

  • 1Department of Psychiatry, National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.

Frontiers in Cell and Developmental Biology
|May 31, 2021
PubMed
Summary
This summary is machine-generated.

Schizophrenia causes remain unclear, but GABAergic system dysfunction is a consistent finding. This review explores mechanisms of this GABAergic dysfunction in schizophrenia research.

Keywords:
GABAergic systemanimal modelsoscillationsschizophreniastem cells

More Related Videos

Whole-cell Currents Induced by Puff Application of GABA in Brain Slices
07:32

Whole-cell Currents Induced by Puff Application of GABA in Brain Slices

Published on: October 12, 2017

9.6K
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K

Related Experiment Videos

Last Updated: Nov 4, 2025

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
07:51

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

17.6K
Whole-cell Currents Induced by Puff Application of GABA in Brain Slices
07:32

Whole-cell Currents Induced by Puff Application of GABA in Brain Slices

Published on: October 12, 2017

9.6K
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Molecular Biology

Background:

  • Schizophrenia etiology remains largely unknown despite extensive research.
  • Numerous hypotheses exist, yet definitive genes or core pathological mechanisms are absent.
  • GABAergic system dysfunction is a consistently reported feature in schizophrenia.

Purpose of the Study:

  • To review recent advancements in understanding GABAergic system dysfunction in schizophrenia.
  • To explore the mechanisms underlying GABAergic dysfunction and associated loops in schizophrenia.
  • To identify potential therapeutic targets within the GABAergic system for schizophrenia.

Main Methods:

  • Literature review of studies on schizophrenia and the GABAergic system.
  • Analysis of research focusing on molecular and circuit-level mechanisms.
  • Synthesis of findings related to GABAergic dysfunction and its implications.

Main Results:

  • Consistent evidence points to widespread GABAergic deficits in schizophrenia.
  • Specific GABAergic interneuron populations and pathways are implicated.
  • Dysfunctional GABAergic signaling contributes to network abnormalities observed in schizophrenia.

Conclusions:

  • GABAergic system dysfunction is a critical component of schizophrenia pathophysiology.
  • Further research into these mechanisms may reveal novel therapeutic strategies.
  • Targeting the GABAergic system holds promise for future schizophrenia treatments.